Analysis of polymorphism of MAGE-A1 gene and its expression in hepatocellular carcinoma tissues

CHEN Hong-song,WEI Lai

DOI: https://doi.org/10.3969/j.issn.1008-1704.2006.02.008

2006-01-01

Abstract:Objective To investigate the expression of MAGE-A1 gene in hepatocellular carcinoma (HCC) and if there were single nucletide polymorphisms (CSNP) in MAGE-A1 gene.Methods RT-PCR was used to examine the expression of MAGE-A1 mRNA in tumor tissues of 49 HCC patients. The PCR products were sequenced directly. Genomic DNAs were extracted from cancerous, paracancerous tissues, and peripheral blood cells of 43 HCC patients. PCR amplification of MAGE-A1 DNA and sequencing the PCR products were performed.Results MAGE-A1 was expressed in 22 of 49 tumor tissues (44.9%) of HCC patients in mRNA level. 43 PCR products from genomic DNA were sequenced and two kinds of polymorphisms were found. One was found in 16/43 (37.2%) cases with three nucleotide acid changes (C159T, A272G and G393A), and was named as TGA polymorphism. This kind of polymorphism resulted in the substitution of two amino acid residues (T32A and R72Q). The other was found in 7/43 patients with three nucleotide acid changes (A272G, C991T and A1125G), and was named as GTG polymorphism, which resulted in one amino acid residue changed (T32A). Conclusion The expression rate of MAGE-A1 gene in human hepatocellular carcinoma is 44.9%. There are three polymorphisms of MAGE-A1 gene involved in SNP, which include the wild type of MAGE-A1 gene. The rate of MAGE-A1 expression has no relation to AFP value and polymorphism.